- Delisting of AMCs under PvPI (Notices)
- Order Issued by National Medical Commission for Enrolment of Medical Colleges as Adverse Drug Reactions (ADR) Monitoring Centres Under PvPI
- Advisory for Reporting ADRs due to Hydroxychloroquine in COVID-19
- Office Orders
- Drug safety label change of Rabies Vaccine (Human) marketed in India (656KB,
) - Ministry Circulars
- Sensitization for the monitoring & reporting of Adverse Reactions related to the use of SGLT2 inhibitors
- Revised advisory on the use of Hydroxychloroquine (HCQ) as prophylaxis for COVID-19 infection (in supersession of previous advisory dated 23rd March,2020)
- Notice Regarding Hydroxychloroquine Sulphate IPRS
- Office order for submission of Source Documents
- Circular for Govt./Non Govt./Corporate Hospital (536KB, )
- Office Memorandum (Evaluation of PSURs data) (469KB, )